Detalhe da pesquisa
1.
Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis.
Lancet Oncol
; 23(4): 514-520, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271804
2.
Educating physicians on strong opioids by descriptive versus simulated-experience formats: a randomized controlled trial.
BMC Med Educ
; 22(1): 741, 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289483
3.
[Overtreatment at the End of Life in Oncology]. / Übertherapie am Lebensende in der Onkologie.
Ther Umsch
; 79(1): 53-60, 2022 02.
Artigo
em Alemão
| MEDLINE | ID: mdl-35100824
4.
Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.
Br J Haematol
; 183(1): 96-103, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028023
5.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061295
6.
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Haematologica
; 100(7): 935-44, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26001791
7.
Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.
Eur J Clin Pharmacol
; 71(9): 1129-38, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26169297
8.
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.
Blood
; 120(9): 1868-76, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22442346
9.
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Haematologica
; 99(1): 103-10, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23911702
10.
Peripheral blood sCD3⻠CD4⺠T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.
Hematol Oncol
; 32(1): 16-21, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23798351
11.
Submicroscopic genomic rearrangements change gene expression in T-cell large granular lymphocyte leukemia.
Eur J Haematol
; 93(2): 143-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24649974
12.
Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.
Cancer Cell
; 10(5): 363-74, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17097559
13.
[Orphan drugs from the perspective of the Drug Commission of the German Medical Association : Opportunities and challenges]. / Orphan Drugs aus Sicht der Arzneimittelkommission der deutschen Ärzteschaft : Chancen und Herausforderungen.
Internist (Berl)
; 60(4): 399-404, 2019 04.
Artigo
em Alemão
| MEDLINE | ID: mdl-30859278
14.
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.
Blood
; 117(11): 3163-71, 2011 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21228332
15.
NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
Haematologica
; 98(6): 928-36, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23349303
16.
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Haematologica
; 98(3): 428-32, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875627
17.
[New drugs in oncology--features of clinical trials for market authorisation and arguments for the rapid implementation of independent clinical trials following approval]. / Neue Arzneimittel in der Onkologie: Merkmale klinischer Zulassungsstudien und Argumente für die rasche Durchführung unabhängiger klinischer Studien nach der Zulassung.
Onkologie
; 36 Suppl 2: 17-22, 2013.
Artigo
em Alemão
| MEDLINE | ID: mdl-23549032
18.
CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia.
Blood
; 115(18): 3763-71, 2010 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20228269
19.
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.
Blood
; 115(16): 3206-14, 2010 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20154213
20.
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.
Haematologica
; 97(3): 402-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058224